Valuation: Tetratherix Limited

Market Cap 354M 251M 217M 204M 185M 348M 23.99B 2.39B 933M 12.01B 942M 921M 39.92B P/E 2026 *
-42.2x
P/E 2027 * -74.9x
Enterprise Value 330M 234M 202M 190M 173M 324M 22.35B 2.22B 869M 11.19B 877M 858M 37.19B EV / Sales 2026 *
45.5x
EV / Sales 2027 * 38.3x
Free-Float
36.03%
Yield 2026 *
-
Yield 2027 * -
1 day+2.62%
1 week-13.38%
Current month-10.47%
1 month-4.99%
3 months+33.40%
6 months+80.27%
Current year+103.35%
1 week 6.5
Extreme 6.5
7.83
1 month 6.5
Extreme 6.5
8.08
Current year 3.09
Extreme 3.09
8.08
1 year 3.09
Extreme 3.09
8.08
3 years 2.88
Extreme 2.88
8.08
5 years 2.88
Extreme 2.88
8.08
10 years 2.88
Extreme 2.88
8.08
Manager TitleAgeSince
Chief Operating Officer - 2015-08-31
Chief Executive Officer - 2021-08-31
Chief Tech/Sci/R&D Officer - 2021-08-31
Director TitleAgeSince
Director/Board Member - 2015-07-31
Chairman - 2024-12-31
Director/Board Member - 2021-08-31
Change 5-day change 1-year change 3-year change Capi.($)
+2.62%-13.38%+46.59% - 251M
-1.78%-1.68%+1.48%+15.31% 48.42B
+0.85%-0.70%+460.88%+563.55% 43.66B
-2.40%-0.23%+8.13%+71.41% 39.51B
-2.01%-0.85%+23.85%+8.73% 38.95B
-0.50%+0.85%+20.60%+49.65% 32.61B
+0.38%-3.23% - - 16.32B
-0.59%-2.06%+26.35%+118.09% 16.15B
+0.49%+0.92%+4.11%+23.67% 14.16B
-0.43%+4.70%+78.74%+33.31% 13.37B
Average -0.34%-0.90%+74.52%+110.46% 26.34B
Weighted average by Cap. -0.91%+0.58%+95.78%+132.95%

Financials

2026 *2027 *
Net sales 7.25M 5.14M 4.44M 4.17M 3.79M 7.13M 491M 48.88M 19.11M 246M 19.3M 18.88M 818M 8.9M 6.31M 5.45M 5.12M 4.66M 8.76M 603M 60M 23.46M 302M 23.69M 23.17M 1B
Net income -7.7M -5.46M -4.71M -4.43M -4.03M -7.58M -522M -51.91M -20.3M -261M -20.49M -20.05M -869M -7M -4.96M -4.29M -4.03M -3.66M -6.89M -475M -47.19M -18.45M -238M -18.63M -18.23M -790M
Net Debt -24.2M -17.16M -14.82M -13.93M -12.67M -23.81M -1.64B -163M -63.8M -822M -64.42M -63.03M -2.73B -13.27M -9.41M -8.12M -7.63M -6.94M -13.05M -899M -89.46M -34.98M -450M -35.32M -34.55M -1.5B
Logo Tetratherix Limited
Tetratherix Limited is an Australia-based company, which has developed a bio stealth fluid matrix that evolves regenerative medicine. The Company's biomaterial platform is built with polymer programming akin to Medical Lego to form implantable products to solve a range of clinical problems. The material is an injectable fluid to avoid causing damage to the body during its application. Upon injection, triggered by physiological temperature, a 3D matrix is formed that physically integrates and adheres to the target tissue. Tegenix and TegenEOS products are developed as a carrier designed to be mixed with a broad array of bone graft materials (BGMs) for dental, oral and orthopedic applications. TetraDerm products can be used in any surgical incision site to reduce scarring. Tutelix products are intended for use as a spacer to reduce side effects from radiation therapy in prostate cancer. It has established its manufacturing center in Sydney, featuring a cleanroom production facility.
Employees
-
Date Price Change Volume
26-08-14 A$6.670 +2.62% 6,162
26-08-13 A$6.500 -8.45% 16,699
26-08-12 A$7.100 -3.01% 20,866
26-08-11 A$7.320 -2.66% 25,672
26-08-10 A$7.520 -2.34% 22,369
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
6.670AUD
Average target price
6.602AUD
Spread / Average Target
-1.01%

Annual profits - Rate of surprise